Excellent outcome after consolidation with autologous transplantation in patients with core binding factor acute myeloid leukemia

Bone Marrow Transplant. 2020 Aug;55(8):1690-1693. doi: 10.1038/s41409-019-0762-3. Epub 2019 Dec 3.

Authors

Martin Sula^#¹, Ulrike Bacher^#^{2

3}, Elisabeth Oppliger Leibundgut², Behrouz Mansouri Taleghani², Urban Novak¹, Thomas Pabst⁴

Affiliations

¹ Department of Medical Oncology, University Hospital and University of Bern, Bern, Switzerland.
² Department of Hematology, University Hospital and University of Bern, Bern, Switzerland.
³ Center of Laboratory Medicine, University Hospital and University of Bern, Bern, Switzerland.
⁴ Department of Medical Oncology, University Hospital and University of Bern, Bern, Switzerland. [email protected].

^# Contributed equally.

PMID: 31796871
DOI: 10.1038/s41409-019-0762-3

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Core Binding Factors
Cytarabine
Hematopoietic Stem Cell Transplantation*
Humans
Leukemia, Myeloid, Acute* / therapy
Remission Induction
Transplantation, Autologous

Substances

Core Binding Factors
Cytarabine